Baxter
BAX
#1109
Rank
โ‚ฌ15.69 B
Marketcap
30,67ย โ‚ฌ
Share price
-0.75%
Change (1 day)
-20.15%
Change (1 year)

Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.

Revenue for Baxter (BAX)

Revenue in 2024 (TTM): โ‚ฌ11.94 Billion

According to Baxter's latest financial reports the company's current revenue (TTM ) is โ‚ฌ11.88 Billion. a decrease over the revenue in the year 2023 that were of โ‚ฌ12.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Baxter from 1996 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ12.35 B-0.34%
2023 โ‚ฌ12.39 B-10.13%
2022 โ‚ฌ13.79 B22.2%
2021 โ‚ฌ11.28 B18.95%
2020 โ‚ฌ9.49 B-6.43%
2019 โ‚ฌ10.14 B4.33%
2018 โ‚ฌ9.72 B10.44%
2017 โ‚ฌ8.80 B-8.9%
2016 โ‚ฌ9.66 B5.98%
2015 โ‚ฌ9.11 B-26.97%
2014 โ‚ฌ12.48 B13.46%
2013 โ‚ฌ11.00 B2.57%
2012 โ‚ฌ10.72 B0.28%
2011 โ‚ฌ10.69 B10.8%
2010 โ‚ฌ9.65 B10.12%
2009 โ‚ฌ8.76 B-0.73%
2008 โ‚ฌ8.83 B14.5%
2007 โ‚ฌ7.71 B-1.92%
2006 โ‚ฌ7.86 B-5.4%
2005 โ‚ฌ8.31 B18.61%
2004 โ‚ฌ7.00 B-1%
2003 โ‚ฌ7.08 B-7.88%
2002 โ‚ฌ7.68 B-11.42%
2001 โ‚ฌ8.67 B18.53%
2000 โ‚ฌ7.32 B15.46%
1999 โ‚ฌ6.34 B22.34%
1998 โ‚ฌ5.18 B0.2%
1997 โ‚ฌ5.17 B12.87%
1996 โ‚ฌ4.58 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ205.29 B 1,628.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.88 B 75.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.47 B 30.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.07 B 60.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.93 B-92.10%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ39.62 B 233.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.27 B-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.88 B-16.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.67 B 158.24%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ2.20 B-81.47%๐Ÿ‡บ๐Ÿ‡ธ USA